Category Archives: Drug prices

Canada-EU Trade Deal Will Cost Canadians Hundreds Of Millions In Extra Drug Costs: PBO It will take longer for generic drugs to reach the market under the terms of CETA.

Source: Huffpost | April 27, 2018 OTTAWA — An extension of drug patent protections in the Canada-EU free trade deal could end up costing Canadians an estimated $392 million a year, and federal coffers up to $270 million more annually, … Continue reading

Posted in Canada, CETA, Drug prices | Leave a comment

Scottish government urged to make breast cancer drug available to Scots

Source: The National | April 24, 2018 A WOMAN forced to choose between accessing a breast cancer drug and moving back to be near family in Scotland has urged Holyrood (Scottish government) to help patients. Dunise MacIver was working in London when doctors … Continue reading

Posted in Access to Medicins, Cancer, Compulsory Licensing, Diseases/Therapies, Drug prices | Leave a comment

Scottish Compulsory Licensing campaign launches today

Highlighting a new campaign aimed at the Scottish government on the price of Roche’s pertuzumab for breast cancer Dunise is a Scottish woman with breast cancer. Right now she is getting access to a drug pertuzumab (Perjeta) because she live in England.

Posted in Cancer, Drug prices, Protest&Campaigns, Uncategorized, Upcoming events | Leave a comment

Will the Trump tariffs on China raise drug prices for Americans?

by Ed Silverama, StatNews | April 4, 2018 Now that the Trump administration has proposed 25 percent tariffs on thousands of Chinese-made products, including raw ingredients for a slew of medicines, there are concerns that prices for these products may rise, … Continue reading

Posted in Drug prices, Generics, Uncategorized | Leave a comment

Dutch hospital challenges big pharma by making own version of very pricey drug

by Robin Pascoe, The Dutch News | April 5, 2018 Amsterdam’s AMC teaching hospital is to start making its own version of a licenced drug to treat a rare metabolic disorder because the medicine is no longer covered by health insurance … Continue reading

Posted in Bad Pharma, Drug prices, Uncategorized | Leave a comment

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.

Source: Kaiser Health News Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations. Even as these patient groups grow in number … Continue reading

Posted in Bad Pharma, Big Pharma myths, Drug prices, Price hikes, Price Negotiations, Uncategorized | Leave a comment

Why do new medicines cost so much, and what can we do about it? The cost of new drugs is putting increasing pressure on people in both rich and poor countries. Sarah Boseley explains why it’s a burning issue

Source: The Guardian|April 09, 2018 Why does it matter what medicines cost? If you are lucky enough to live in a country with comprehensive state-funded healthcare, such as the UK, you probably have no idea how much medicines really cost. … Continue reading

Posted in Access to Medecines, Access to Medicins, Drug prices, IP Rights, Patent, Pricing, R&D | Leave a comment